Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

32,282 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Establishment of a risk stratification model based on the combination of post-treatment serum squamous cell carcinoma antigen levels and FIGO stage of cervical cancer for treatment and surveillance decision-making.
Shi L, Liu Y, Li J, Kou J, Ouyang Y, Chen F, Huang X, Huo L, Huang L, Cao X. Shi L, et al. Among authors: huang l, huang x. J Cancer Res Clin Oncol. 2023 Aug;149(9):5999-6007. doi: 10.1007/s00432-022-04558-1. Epub 2023 Jan 9. J Cancer Res Clin Oncol. 2023. PMID: 36624190 Free PMC article.
Correction: Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells.
Yu Z, Guo W, Ma X, Zhang B, Dong P, Huang L, Wang X, Wang C, Huo X, Yu W, Yi C, Xiao Y, Yang W, Qin Y, Yuan Y, Meng S, Liu Q, Deng W. Yu Z, et al. Among authors: huang l. Mol Cancer. 2023 Sep 2;22(1):144. doi: 10.1186/s12943-023-01852-5. Mol Cancer. 2023. PMID: 37660130 Free PMC article. No abstract available.
32,282 results
You have reached the last available page of results. Please see the User Guide for more information.